Matches in Wikidata for { <http://www.wikidata.org/entity/Q62054930> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q62054930 description "assaig clínic" @default.
- Q62054930 description "clinical trial" @default.
- Q62054930 description "clinical trial" @default.
- Q62054930 description "clinical trial" @default.
- Q62054930 description "clinical trial" @default.
- Q62054930 description "ensaio clínico" @default.
- Q62054930 description "ensayo clínico" @default.
- Q62054930 description "ensayu clínicu" @default.
- Q62054930 description "essai clinique" @default.
- Q62054930 description "klinisch onderzoek" @default.
- Q62054930 description "клінічне випробування" @default.
- Q62054930 description "临床试验" @default.
- Q62054930 name "Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma" @default.
- Q62054930 type Item @default.
- Q62054930 label "Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma" @default.
- Q62054930 prefLabel "Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma" @default.
- Q62054930 P1050 Q62054930-56EE0CF2-81F4-4BA5-A229-9BD7C1C5B16A @default.
- Q62054930 P1050 Q62054930-68EB2F2D-CEB1-4147-BD05-90A65631FECD @default.
- Q62054930 P1050 Q62054930-79C90B31-462E-4A12-A5C1-08E3AEE9F838 @default.
- Q62054930 P1132 Q62054930-2B1ACEDF-2AC3-497E-900C-F2F1ECC1CEB2 @default.
- Q62054930 P1476 Q62054930-1C7D734B-9B9E-4654-A1C2-5BA18E9717F3 @default.
- Q62054930 P1813 Q62054930-5B2BE3A7-EC5F-45D1-8300-342D3D09A1F8 @default.
- Q62054930 P2899 Q62054930-E632F164-7E6B-4B05-816D-8BD29F6AC7AE @default.
- Q62054930 P3098 Q62054930-FC333386-EEFC-409F-8097-AC6992B63662 @default.
- Q62054930 P31 Q62054930-BDD4892F-D983-41EF-A8DF-69907328A334 @default.
- Q62054930 P580 Q62054930-05226B2D-57E4-4A0A-9E21-A0F1AA868EC3 @default.
- Q62054930 P582 Q62054930-AFF064A3-91AD-4B07-973E-B66CB87FC1AC @default.
- Q62054930 P6099 Q62054930-B9364FCC-FBDC-46F5-9C32-08C96B072A2B @default.
- Q62054930 P6153 Q62054930-9BED5C9A-B7B4-4AB9-B7CD-EAD5471BB3B6 @default.
- Q62054930 P8005 Q62054930-6c5c4449-4b62-3eaa-2073-50cad1291f09 @default.
- Q62054930 P8363 Q62054930-6DEFA8D8-2B4D-4382-A2A4-605002934D63 @default.
- Q62054930 P859 Q62054930-682EB585-D4FD-4231-86C0-86A98DE7414F @default.
- Q62054930 P921 Q62054930-1F69C1FC-5E8B-419B-9E0D-D20AC49A2EA8 @default.
- Q62054930 P1050 Q21116733 @default.
- Q62054930 P1050 Q35869 @default.
- Q62054930 P1050 Q5958765 @default.
- Q62054930 P1132 "+93" @default.
- Q62054930 P1476 "A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of Fevipiprant Once Daily Plus Standard-of-care (SoC) for Assessment of the Efficacy in Reduction of Nasal Polyp Size in Patients With Nasal Polyposis and Concomitant Asthma." @default.
- Q62054930 P1813 "THUNDER" @default.
- Q62054930 P2899 "+18" @default.
- Q62054930 P3098 "NCT03681093" @default.
- Q62054930 P31 Q30612 @default.
- Q62054930 P580 "2019-01-21T00:00:00Z" @default.
- Q62054930 P582 "2020-07-06T00:00:00Z" @default.
- Q62054930 P6099 Q42824827 @default.
- Q62054930 P6153 Q507154 @default.
- Q62054930 P8005 Q76649790 @default.
- Q62054930 P8363 Q78089383 @default.
- Q62054930 P859 Q507154 @default.
- Q62054930 P921 Q13100823 @default.